WallStreetZenWallStreetZen

NASDAQ: OCX
Oncocyte Corp Stock Forecast, Predictions & Price Target

Analyst price target for OCX

Based on 3 analysts offering 12 month price targets for Oncocyte Corp.
Min Forecast
$4.00+24.61%
Avg Forecast
$4.42+37.6%
Max Forecast
$5.00+55.76%

Should I buy or sell OCX stock?

Based on 3 analysts offering ratings for Oncocyte Corp.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 66.67%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OCX stock forecasts and price targets.

OCX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-16
lockedlocked$00.00+00.00%2024-04-17
lockedlocked$00.00+00.00%2024-04-15

1 of 1

Forecast return on equity

Is OCX forecast to generate an efficient return?
Company
-297.56%
Industry
-7.52%
Market
13.14%
OCX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OCX forecast to generate an efficient return on assets?
Company
-48.58%
Industry
8.6%
OCX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OCX earnings per share forecast

What is OCX's earnings per share in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$2.58

OCX vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
OCX$3.21$4.42+37.60%Buy
TTOO$5.07$3.00-40.83%Hold
DRIO$1.20$4.00+233.33%Strong Buy
NOTV$1.95$5.25+169.23%Hold
XGN$1.96$7.00+257.14%Strong Buy

Oncocyte Stock Forecast FAQ

Is Oncocyte Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: OCX) stock is to Buy OCX stock.

Out of 3 analysts, 0 (0%) are recommending OCX as a Strong Buy, 2 (66.67%) are recommending OCX as a Buy, 1 (33.33%) are recommending OCX as a Hold, 0 (0%) are recommending OCX as a Sell, and 0 (0%) are recommending OCX as a Strong Sell.

If you're new to stock investing, here's how to buy Oncocyte stock.

What is OCX's earnings growth forecast for 2024-2024?

(NASDAQ: OCX) Oncocyte's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Oncocyte's earnings in 2024 is -$40,861,000.

In 2024, OCX is forecast to generate -$34,480,763 in earnings, with the lowest earnings forecast at -$34,480,763 and the highest earnings forecast at -$34,480,763.

What is OCX's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: OCX) forecast ROE is -297.56%, which is considered weak.

What is OCX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year OCX price target, the average OCX price target is $4.42, with the highest OCX stock price forecast at $5.00 and the lowest OCX stock price forecast at $4.00.

On average, Wall Street analysts predict that Oncocyte's share price could reach $4.42 by May 16, 2025. The average Oncocyte stock price prediction forecasts a potential upside of 37.6% from the current OCX share price of $3.21.

What is OCX's Earnings Per Share (EPS) forecast for 2024-2024?

(NASDAQ: OCX) Oncocyte's current Earnings Per Share (EPS) is -$5.08. In 2024, OCX's EPS is forecast to hit -$2.58 (min: -$2.58, max: -$2.58).

What is OCX's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: OCX) forecast ROA is -48.58%, which is lower than the forecast US Diagnostics & Research industry average of 8.6%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.